Sign inGet started

Brown Dennis M

Insider CIK 1569520 · DMPI Chief Scientific Officer, Director, 10% owner · CLCS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KTRA Kintara Therapeutics, Inc. A Award deriv2023-08-302023-09-0110,175— $010,175SEC↗
KTRA Kintara Therapeutics, Inc. W Will2023-01-052023-01-06363— $05,302SEC↗
KTRA Kintara Therapeutics, Inc. A Award deriv2022-08-012022-08-03720,260— $0720,260SEC↗
KTRA Kintara Therapeutics, Inc. A Award2022-08-012022-08-03240,087— $0246,905SEC↗
CLCS Cell Source, Inc. J Other2021-06-302021-07-072,976$0.75 $2.2K114,927SEC↗
KTRA Kintara Therapeutics, Inc. C Conversion deriv2021-04-292021-04-293,000— $00SEC↗
KTRA Kintara Therapeutics, Inc. C Conversion2021-04-292021-04-29750— $06,818SEC↗
KTRA Kintara Therapeutics, Inc. J Other2021-04-292021-04-296— $06,068SEC↗
KTRA Kintara Therapeutics, Inc. J Other2021-03-312021-03-3117— $06,062SEC↗
KTRA Kintara Therapeutics, Inc. J Other2020-12-312021-01-0417— $06,045SEC↗
CLCS Cell Source, Inc. J Other2020-12-292021-06-103,025$0.75 $2.3K111,951SEC↗
KTRA Kintara Therapeutics, Inc. J Other2020-09-302020-09-3017— $06,028SEC↗
KTRA Kintara Therapeutics, Inc. A Award deriv2020-09-222020-09-2460,000— $060,000SEC↗
KTRA Kintara Therapeutics, Inc. A Award deriv2020-09-152020-09-1787,437— $087,437SEC↗
CLCS Cell Source, Inc. A Award deriv2020-08-192021-06-10450,000— $0450,000SEC↗
CLCS Cell Source, Inc. J Other2020-06-302021-06-102,992$0.75 $2.2K108,926SEC↗
DMPI DelMar Pharmaceuticals, In J Other2020-06-302020-06-3017— $06,011SEC↗
DMPI DelMar Pharmaceuticals, In A Award deriv2020-06-262020-06-3052,756— $0100,000SEC↗
DMPI DelMar Pharmaceuticals, In A Award deriv2020-06-262020-06-30250,000— $0250,000SEC↗
DMPI DelMar Pharmaceuticals, In J Other2020-03-312020-03-3117— $05,994SEC↗
CLCS Cell Source, Inc. J Other2019-12-312021-06-105,934$0.75 $4.5K105,934SEC↗
DMPI DelMar Pharmaceuticals, In J Other2019-12-312020-01-0217— $05,977SEC↗
DMPI DelMar Pharmaceuticals, In G Gift2019-12-272020-01-027,500— $05,960SEC↗
KTRA Kintara Therapeutics, Inc. A Award deriv2019-11-122020-09-24250,000— $0250,000SEC↗
DMPI DelMar Pharmaceuticals, In A Award deriv2019-11-122019-11-14250,000— $0250,000SEC↗
DMPI DelMar Pharmaceuticals, In J Other2019-09-302019-10-0117— $013,460SEC↗
DMPI DelMar Pharmaceuticals, In A Award deriv2019-09-052019-09-0947,244— $047,244SEC↗
DMPI DelMar Pharmaceuticals, In A Award deriv2019-09-052019-09-0952,756— $052,756SEC↗
DMPI DelMar Pharmaceuticals, In J Other2019-06-282019-07-0117— $013,443SEC↗
DMPI DelMar Pharmaceuticals, In J Other2019-03-292019-04-01169$0.49 $83134,260SEC↗
CLCS Cell Source, Inc. A Award deriv2019-02-132021-06-106,667$7.50 $50.0K6,667SEC↗
DMPI DelMar Pharmaceuticals, In J Other2018-12-312019-01-02169$0.34 $57134,091SEC↗
DMPI DelMar Pharmaceuticals, In G Gift2018-12-212019-01-0285,000— $0133,922SEC↗
DMPI DelMar Pharmaceuticals, In J Other2018-09-282018-10-01169$3.20 $541218,922SEC↗
DMPI DelMar Pharmaceuticals, In J Other2018-06-292018-07-03169$3.20 $541218,753SEC↗
DMPI DelMar Pharmaceuticals, In J Other2018-03-302018-04-03169$3.20 $541218,584SEC↗
DMPI DelMar Pharmaceuticals, In J Other2017-12-312018-01-03169$3.20 $541218,415SEC↗
DMPI DelMar Pharmaceuticals, In G Gift2017-12-132018-01-03129,600— $0218,246SEC↗
DMPI DelMar Pharmaceuticals, In J Other2017-09-292017-10-02169$3.20 $541885,346SEC↗
DMPI DelMar Pharmaceuticals, In J Other2017-06-302017-07-05169$3.20 $541885,177SEC↗
DMPI DelMar Pharmaceuticals, In J Other2017-03-312017-04-03169$3.20 $541885,008SEC↗
DMPI DelMar Pharmaceuticals, In A Award deriv2017-02-172017-02-2293,600— $093,600SEC↗
DMPI DelMar Pharmaceuticals, In C Conversion deriv2017-01-312017-02-02125,000— $00SEC↗
DMPI DelMar Pharmaceuticals, In C Conversion2017-01-312017-02-02125,000$1.54 $192.5K884,839SEC↗
DMPI DelMar Pharmaceuticals, In J Other2016-12-312017-01-03169$3.20 $541759,839SEC↗
DMPI DelMar Pharmaceuticals, In J Other2016-10-032016-10-05169$3.20 $541759,670SEC↗
DMPI DelMar Pharmaceuticals, In J Other2016-07-182016-07-19115$3.20 $368759,501SEC↗
DMPI DelMar Pharmaceuticals, In P Buy deriv2016-04-292016-05-033,000$8.00 $24.0K3,000SEC↗
DMPI DelMar Pharmaceuticals, In P Buy deriv2015-07-252015-07-2810,000— $085,000SEC↗
DMPI DelMar Pharmaceuticals, In P Buy2015-07-252015-07-2810,000$0.60 $6.0K3,037,542SEC↗
DMPI DelMar Pharmaceuticals, In P Buy deriv2015-07-222015-07-2375,000— $075,000SEC↗
DMPI DelMar Pharmaceuticals, In P Buy2015-07-222015-07-2375,000$0.60 $45.0K3,027,542SEC↗
DMPI DelMar Pharmaceuticals, In J Other2014-09-302014-10-02278,530$1.00 $278.5K278,530SEC↗
DMPI DelMar Pharmaceuticals, In P Buy2014-03-182014-03-2010,000$1.30 $13.0K2,952,542SEC↗
DMPI DelMar Pharmaceuticals, In P Buy2014-03-042014-03-045,000$1.56 $7.8K2,942,542SEC↗
DMPI DelMar Pharmaceuticals, In A Award deriv2013-08-162013-08-20350,000— $0350,000SEC↗
DMPI DelMar Pharmaceuticals, In C Conversion deriv2013-08-022013-08-0610,000— $090,000SEC↗
DMPI DelMar Pharmaceuticals, In C Conversion deriv2013-08-022013-08-0624,000— $0216,000SEC↗
DMPI DelMar Pharmaceuticals, In C Conversion2013-08-022013-08-0634,000— $02,937,542SEC↗